The ALOG chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALOG chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ALOG stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ALOG Detailed Price Forecast - CNN Money||View ALOG Detailed Summary - Google Finance|
|View ALOG Detailed Summary - Yahoo! Finance||View ALOG Stock Research & Analysis - Zacks.com|
|View ALOG Trends & Analysis - Trade-Ideas||View ALOG Major Holders - Barrons|
|View ALOG Call Transcripts - NASDAQ||View ALOG Breaking News & Analysis - Seeking Alpha|
|View ALOG Annual Report - CompanySpotlight.com||View ALOG OTC Short Report - OTCShortReport.com|
|View ALOG Fundamentals - TradeKing||View ALOG SEC Filings - Bar Chart|
|View Historical Prices for ALOG - The WSJ||View Performance/Total Return for ALOG - Morningstar|
|View the Analyst Estimates for ALOG - MarketWatch||View the Earnings History for ALOG - CNBC|
|View the ALOG Earnings - StockMarketWatch||View ALOG Buy or Sell Recommendations - MacroAxis|
|View the ALOG Bullish Patterns - American Bulls||View ALOG Short Pain Metrics - ShortPainBot.com|
|View ALOG Stock Mentions - StockTwits||View ALOG Stock Mentions - PennyStockTweets|
|View ALOG Stock Mentions - Twitter||View ALOG Investment Forum News - Investor Hub|
|View ALOG Stock Mentions - Yahoo! Message Board||View ALOG Stock Mentions - Seeking Alpha|
|View Insider Transactions for ALOG - SECform4.com||View Insider Transactions for ALOG - Insider Cow|
|View ALOG Major Holdings Summary - CNBC||View Insider Disclosure for ALOG - OTC Markets|
|View Insider Transactions for ALOG - Yahoo! Finance||View Institutional Holdings for ALOG - NASDAQ|
|View ALOG Stock Insight & Charts - FinViz.com||View ALOG Investment Charts - StockCharts.com|
|View ALOG Stock Overview & Charts - BarChart||View ALOG User Generated Charts - Trading View|
Blog Exposure - Eli Lilly's Taltz(R) Meets Primary Endpoint in Phase-3 Study for Treatment of Ankylosing Spondylitis
Posted on Monday July 02, 2018
LONDON, UK / ACCESSWIRE / July 2, 2018 / If you want access to our free research report on Eli Lilly and Co. (NYSE: LLY) ("Eli Lilly"), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=LLY as the Company's latest news hit the wire. On June 28, 2018, the Company declared that Taltz® (ixekizumab) met the primary and major secondary endpoints in COAST-W, which is a Phase-3 study evaluating Taltz® for the treatment of Ankylosing Spondylitis (AS), also known as radiographic axial spondyloarthritis (r-axSpA). Active-Investors.com is currently working on the research report for Analogic Corporation (NASDAQ: ALOG), which also belongs to the Healthcare sector as the Company Eli Lilly.
NEW YORK, June 22, 2018 /PRNewswire/ -- Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court for The District of Massachusetts, Case No. 1:18-cv-11301, on behalf of shareholders of Analogic Corporation, ("Analogic" or the "Company") (ALOG) who held Analogic securities and have been harmed by Analogic and its board of directors' (the "Board") for alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") in connection with the sale of the Company to affiliates of Altaris Capital Partners, LLC ("Altaris"). In pursuing the unfair plan to facilitate the acquisition of Analogic by Altaris for grossly inadequate consideration, the Proxy Statement exposes some details of the highly flawed sales process, but the Proxy Statement fails to disclose a myriad of material facts concerning the Proposed Transaction, preventing shareholders from casting an informed vote for or against the Proposed Transaction.
Analogic Stockholders Approve Acquisition by an Affiliate of Altaris Capital Partners
Posted on Thursday June 21, 2018
Analogic Corporation (ALOG) (“the Company” or “Analogic”), a provider of leading-edge healthcare and security solutions, today announced that its stockholders have approved the previously announced merger agreement under which an affiliate of Altaris Capital Partners, LLC (together with certain affiliated entities, “Altaris”) will acquire all of the outstanding shares of Analogic for $84.00 per share in cash, or approximately $1.1 billion on a fully diluted basis. The approval of the stockholders of Analogic was a condition to the closing of the merger agreement, which has now been satisfied. Of the votes cast at Analogic’s special meeting held on June 21, 2018, 97.66% voted in favor of the merger agreement, which equates to 79.44% of all outstanding shares.
NVIDIA Set to Join S&P 100; FleetCor Technologies to Join S&P 500; Penn Virginia to Join S&P SmallCap 600
Posted on Friday June 15, 2018
NEW YORK , June 15, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 100, S&P 500 and S&P SmallCap 600: NVIDIA Corp. (NASD: NVDA) will replace Time Warner Inc. (NYSE: ...